bet9¹ÙÍø

bet9¹ÙÍø enters digital therapeutics by partnering with Wellthy Therapeutics in India and Brandmed in South Africa to bring together behavioural science, real world clinical evidence and artificial intelligence to provide real time monitoring, coaching and advice to patients.

bet9¹ÙÍø USA furthers AMR stewardship with acquisition of key anti-infective ZEMDRIâ„¢

bet9¹ÙÍø receives Great Place To Work Certification once again.

bet9¹ÙÍø receives final approval for generic version of ±Ê°ù´Ç±¹±ð²Ô³Ù¾±±ô® HFA Inhalation Aerosol (Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation)

bet9¹ÙÍø Foundation supports the set up of Maharashtra's only dedicated pediatric isolation ward for COVID-19

bet9¹ÙÍø - Breathe Free Lanka Pvt Ltd. receives Great Place To Work certification. bet9¹ÙÍø is one of the top 3 pharma companies in Sri Lanka

bet9¹ÙÍø Foundation reaches out to local communities affected by Cyclone Amphan in West Bengal, India by providing essential hygeine and food supplies to those in need.

In June 2020, bet9¹ÙÍø Foundation South Africa together with Miltons Matsemela hosted a virtual Youth Day Run to raise funds for frontline COVID healthcare workers.

bet9¹ÙÍø signs a distribution agreement with Roche Products (India) Pvt. Ltd. to expand scope of the partnership to include, marketing and distribution of Roche’s trademark oncology drugs - Trastuzumab (Herclon), Bevacizumab (Avastin) and Rituximab (Ristova) in India

bet9¹ÙÍø launches remdesivir under its brand name CIPREMI. In May, Gilead Sciences Inc. extended a voluntary non-exclusive license to bet9¹ÙÍø to manufacture and market bet9¹ÙÍø’s generic version of remedisvir called CIPREMI.

bet9¹ÙÍø and Boehringer Ingelheim forge partnership to co-market three oral anti-diabetic drugs - Oboravo® (Empagliflozin), Oboravo Met® (Empagliflozin+Metformin) and Tiptengio® (Empagliflozin+Linagliptin)

bet9¹ÙÍø is granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in India under the brand name Ciplenza. Favipiravir is an off patent, oral anti-viral drug that has been shown to hasten clinical recovery in COVID -19 patients with mild to moderate symptoms.

bet9¹ÙÍø completes 85 years on 17th August 2020.

bet9¹ÙÍø and Stempeutics collaborate for launch of Stempeucel®, first ‘Made in India’ Cell Therapy to treat Critical Limb Ischemia (CLI).

In continuance of its efforts to advance quality education and promote industry-academia collaboration, bet9¹ÙÍø Foundation, funds the set-up of a world class chemistry research laboratory at the Indian Institute of Science Education and Research (IISER) Pune.